24
Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Embed Size (px)

Citation preview

Page 1: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Disintegrins:The Challenge of Nomenclature

Mary Ann McLaneUniversity of Delaware

ISTH Subcommittee on Exogenous Hemostatic FactorsAugust 6, 2005

Page 2: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Snake venom proteins active on the hemostatic system (Markland 1998)

Factor V activating Factor X activating Factor IX activating Prothrombin

activating Fibrinogen clotting Protein C activating Factor IX/factor X-

binding protein Thrombin inhibitor

Phospholipase A Fibrin(ogen)

degradation Plasminogen activation Hemorrhagic Platelet aggregation

inducers Inhibitors of platelet

aggregation Inhibitors of serpins

Page 3: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Snake venom proteins active on the hemostatic system (Markland 1998)

Factor V activatingFactor V activating Factor X activatingFactor X activating Factor IX activatingFactor IX activating Prothrombin

activating Fibrinogen clotting Protein C activating Factor IX/factor X-

binding protein Thrombin inhibitor

Phospholipase APhospholipase A Fibrin(ogen) Fibrin(ogen)

degradationdegradation Plasminogen activationPlasminogen activation HemorrhagicHemorrhagic Platelet aggregation Platelet aggregation

inducersinducers Inhibitors of platelet Inhibitors of platelet

aggregationaggregation Inhibitors of serpinsInhibitors of serpins

1991,2000 “-arin” or “activase” added to

prefixes derived from Latin species name, plus designation of A, B, C or D based on cofactor requirements

Page 4: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Snake venom proteins active on the hemostatic system (Markland 1998)

Factor V activatingFactor V activating Factor X activatingFactor X activating Factor IX activatingFactor IX activating Prothrombin Prothrombin

activatingactivating Fibrinogen clottingFibrinogen clotting Protein C activatingProtein C activating Factor IX/factor X-Factor IX/factor X-

binding proteinbinding protein Thrombin inhibitorThrombin inhibitor

Phospholipase APhospholipase A Fibrin(ogen) Fibrin(ogen)

degradationdegradation Plasminogen activationPlasminogen activation HemorrhagicHemorrhagic Platelet aggregation Platelet aggregation

inducersinducers Inhibitors of platelet

aggregation Inhibitors of serpinsInhibitors of serpins

Page 5: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Disintegrins: 80% “-in”

Page 6: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Disintegrins: 43% “-in” Halysin Salmosin Applagin Kistrin Gabonin, 1, 2 Bothrasperin Cotiarin Jararacin Rhodostomin Crotatoxin Basilicin Durissin Molossin Crotavirin

Cereberin Lutosin Viridin Pyramidin Eristocophin Brevicaudin 1a, 1b, 2b Saxatilin Lachesin Tergeminin Barbourin Alblabrin Falvoridin Triflavin Trigramin

Page 7: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Disintegrins: 36% “-tin” Halystatin Accutin Contortrostatin Acostatin Halysetin Piscivostatin Ussuristatin 1, 2 Bitistatin Arietin Batroxostatin Jarastatin Cerastatin

Cerastin Schistatin Echistatin leukogastinA, B Multisquamatin Ocellatin Eristostatin Elegantin Flavostatin Trimestatin Jerdonatin Obtustatin Viperostatin

Page 8: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Disintegrins: “-statin” Halystatin AccutinAccutin Contortrostatin Acostatin HalysetinHalysetin Piscivostatin Ussuristatin 1, 2 Bitistatin ArietinArietin Batroxostatin Jarastatin Cerastatin

CerastinCerastin Schistatin Echistatin leukogastinA, BleukogastinA, B MultisquamatinMultisquamatin OcellatinOcellatin Eristostatin ElegantinElegantin Flavostatin Trimestatin JerdonatinJerdonatin Obtustatin Viperostatin

Page 9: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Disintegrins: 17% “EF#”

CC5 CC8 EMS11 EC3 EC6 EO4

EO5 EMF10 VA6 VB7 VLO4 VLO5

Page 10: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Disintegrins: 3% “acronym#”

CTF-I CTF-II

Page 11: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Disintegrins: 1% “-or”

adinbitor

Page 12: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Disintegrins since 2004

Jerdonin (Trimeresurus jerdonii)

Bothrostatin (Bothrops jararaca)

Total = 75

Note: No information from the name about whether the protein is a monomer

or dimer

Page 13: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Standardizing nomenclature

Realities “statin” = suffix used for naming class of

HMG-CoA reductase inhibitors for controlling cholesterol levels

Lipitor (atorvastatin) - Pfizer Zocor (simvastatin) - Merck Pravachol (pravastatin) - Bristol-Myers Squibb Lescol (fluvastatin) - Novartis Mevacor (lovastatin) - Merck Crestor (rosuvastatin) - AstraZeneca

Page 14: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Standardizing nomenclature

Realities Subspecies discoveries

Echis…. Echistatin Echistatin Echistatin

Page 15: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Standardizing nomenclature

Realities Subspecies discoveries http://www.embl-heidelberg.de

Echis carinatus Echistatin

Echis carinatus sochurecki

Echis sochurecki

1969

1999 2001

Page 16: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Standardizing nomenclature Realities

Genus different, species the same carinatin [Tropidechis carinatus]

Non-disintegrin carinatin [Echis carinatus]

Echistatin 2

http://www.kingsnake.com/oz/snakes/elapids/tcarinata.htm

http://itgmv1.fzk.de/www/itg/uetz/herp/photos/Echis_carinatus2.jpg

Page 17: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Standardizing nomenclature

Realities Genus same, species the same,

different proteins discovered Echistatin Schistatin Carinatin EC3

Page 18: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Standardizing nomenclature

Recommendation Disintegrins prior to 2004 = retain name This standardization committee will

determine how many proteins have been discovered from each genus-species-subspecies (to get the next number)

Include the NCBI protein database http://www.ncbi.nlm.nih.gov/entrez for disintegrins named after cDNA analysis

Page 19: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Standardizing nomenclature

Recommendation New disintegrins are named by

combination of genus-subspecies or species-subspecies Latin name followed by “-min” for monomer or “din” for dimers

Numbered sequentially from that point on

Page 20: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Standardizing nomenclature

Echis carinatus sochurecki Echistatin EC3 EC6 Schistatin Ecarisomin 5 (a monomer)

Page 21: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Standardizing nomenclature

Echis carinatus sochurecki Echistatin EC3 EC6 Schistatin Ecarisomin 5 (a monomer) Ecarisodin 6 (a dimer) Ecarisotin 7 (unsure of structure; cDNA name)

Page 22: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Standardizing nomenclature

Gloydius genus Gloydius blomhoffi brevicaudus

Adinbitor Blobrevidin 2 (a dimer)

Gloydius halys brevicaudus Brevicaudin 1a, 1b, 2b Halybrevimin 4 (a monomer)

Gloydius saxatilis Saxitilin Gloysaxatin 2 (unknown structure)

Page 23: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Standardizing nomenclature

More realities Does not eliminate potential confusion when

genus names change Agkistrodon rhodostoma (1930)

Kistrin (Dennis 1990) Calloselasma rhodostoma (1827, 1994)

Rhodostomin (Au 1991)

“-cetin” is also used for naming C-lectin-like proteins targeting GPIb, GPVI and/or 21

Page 24: Disintegrins: The Challenge of Nomenclature Mary Ann McLane University of Delaware ISTH Subcommittee on Exogenous Hemostatic Factors August 6, 2005

Discussion!